CS261697B1 - 1-methyl-5-/n-n-propyl-n-formyl/-amino-6-uracil and process for preparing thereof - Google Patents
1-methyl-5-/n-n-propyl-n-formyl/-amino-6-uracil and process for preparing thereof Download PDFInfo
- Publication number
- CS261697B1 CS261697B1 CS878787A CS878787A CS261697B1 CS 261697 B1 CS261697 B1 CS 261697B1 CS 878787 A CS878787 A CS 878787A CS 878787 A CS878787 A CS 878787A CS 261697 B1 CS261697 B1 CS 261697B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- methyl
- formyl
- propyl
- amino
- aminouracil
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Predmetom riešenia je 1 -mety 1-5- (N-n- -propyJ-N-formyl)amíno-6-amínouracil a jeho příprava reakciou l-metyl-5-n-propylamíno- -6-amínouracilu s kyselinou mravčou alebo jej reaktívnymi derivátmi. Zlúčenína sa používá ako medziprodukt pre přípravu lieCl- va kardlovaskulárneho systému.The object of the invention is 1-methyl-5- (N-N-propyl-N-formyl) amino-6-aminouracil and its preparation by reacting 1-methyl-5-n-propylamino-6-aminouracil with formic acid or its reactive derivatives . The compound is used as an intermediate for the preparation of the cardiovascular system.
Description
Vynález sa týká nového l-metyl-5-(N-n-propyl-N-formyl) amíno-6-amínour acilu vzorca IThe present invention relates to a novel 1-methyl-5- (N-n-propyl-N-formyl) amino-6-aminoouril of the formula I
CHO . N~ C ř-L- Cl·!'c Cfh lil a sposobu jeho přípravy.CHO. N-C-L-C ° ·? 'Cf c h lil and a process for its preparation.
Zlúčenina vzorca I sa používá ako medziprodukt pre přípravu liečiva kardiovaskulárneho systému. Zlúčenina vzorca I sa připravuje reakciou l-metyl-5-n-propylamíno-6-amínouracilu vzorca II o ' .....The compound of formula I is used as an intermediate for the preparation of a medicament of the cardiovascular system. The compound of formula (I) is prepared by reacting 1-methyl-5-n-propylamino-6-aminouracil of formula (II).
H νΛy nh -ch^c c h3 H ν Λ y nh -ch ^ cch 3
Ako rozpúšťadlo sa m6že použiť voda alebo rozpúšťadlo inertně za podmienok reakcie, ako xylén.As the solvent, water or a solvent inert under the reaction conditions such as xylene can be used.
Podrobnosti jednotlivých spfisobov přípravy sú uvedené v nasledujúcich príkladoch prevedenia, bez toho, že by sa na tieto výlučné obmedzovali.The details of the various methods of preparation are given in the following examples, without being limited to these.
Příklad 1Example 1
61,5 g l-metyl-5-n-propylamíno-6-amínouracilu a 150 ml kyseliny mravčej sa za miešania refluxuje počas 90 minut. Reakčná zmes sa zahusti za vakua a k zvyšku sa přidá 80 mililitrov etanolu, zahřeje sa do varu a přefiltruje. Vysušením sa získá 63,7 g 1-metyl-5- (N-n-propyl-N-formyl )amíno-6-amínouracilu s t. t. 238 až 243 °C.61.5 g of 1-methyl-5-n-propylamino-6-aminouracil and 150 ml of formic acid are refluxed with stirring for 90 minutes. The reaction mixture is concentrated in vacuo and 80 ml of ethanol are added to the residue, heated to boiling and filtered. Drying gave 63.7 g of 1-methyl-5- (N-n-propyl-N-formyl) amino-6-aminouracil, m.p. t. 238 DEG-243 DEG.
Příklad 2Example 2
19,8 g l-metyl-S-n-propylamíno-Ď-amínouracilu sa přidá do 50 ml zmesného anhydridu kyseliny octovej a mravčej a reakčná zmes sa mieša pri teplote 50 °C počas 3,5 hodiny. Spracovaním ako v příklade 1 sa získá 22 g l-metyl-5-(N-n-propyl-N-formyl jamino-6-amínouracilu.19.8 g of 1-methyl-S-n-propylamino-N-aminouracil are added to 50 ml of mixed acetic anhydride and formic anhydride and the reaction mixture is stirred at 50 ° C for 3.5 hours. Working up as in Example 1 gave 22 g of 1-methyl-5- (N-n-propyl-N-formyl jamino-6-aminouracil).
s kyselinou mravčou alebo jej reaktívnymi derivátmi, ako zmesným anhydrldom alebo reaktívnym esterom v organickom alebo vodnoorganickom prostředí pri teplote 15 °C až 150 °C.with formic acid or its reactive derivatives such as mixed anhydride or reactive ester in an organic or aqueous organic medium at a temperature of 15 ° C to 150 ° C.
Postup přípravy zlúčeniny vzorca I podlá vynálezu sa uskutočňuje tak, že sa k 1 mól. dielu zlúčeniny vzorca II přidá 0,8 až 5 mól. dielov kyseliny mravčej alebo jej reaktívneho derivátu, ako zmesného anhydridu alebo reaktívneho esteru. Ako zmesný anhydrid možno použit najmá anhydrid vytvořený s kyselinou octovou, ako reaktívny ester p-nitrofenylester kyseliny mravčej, ako uvádza napr. Mc Omie, J. F. W. (ed) („Protective group in organic chemistry“. New York, Plenům Press 1973). Formylácia s kyselinou mravčou sa móže uskutočniť aj v přítomnosti rozpúšťadla alebo priamo v jej nadbytku.The process for the preparation of the compound of the formula I according to the invention is carried out by adding to 1 mol. of the compound of formula II is added from 0.8 to 5 mol. parts of formic acid or a reactive derivative thereof, such as a mixed anhydride or a reactive ester. The mixed anhydride used may be, in particular, the anhydride formed with acetic acid, such as the reactive ester of p-nitrophenyl formate, e.g. Mc Omie, J. F. W. (ed.) ("Protective group in organic chemistry". New York, Plenum Press 1973). Formic acid formulations can also be carried out in the presence of a solvent or directly in excess.
Příklad 3Example 3
0,95 g l-metyl-5-n-propylamíno-6-ainínouracilu sa refluxuje s 0,85 g p-nitrofenylesteru kyseliny mravčej v 13 ml dimetylformamldu počas 20 minut. Spracovaním ako v příklade 1 sa získá 0,17 g l-metyl-5-(N-n-propyl-N-f ormyl jamíno-6-amínouraciliu.0.95 g of 1-methyl-5-n-propylamino-6-aininouracil is refluxed with 0.85 g of p-nitrophenyl formate in 13 ml of dimethylformamide for 20 minutes. Working up as in Example 1 gave 0.17 g of 1-methyl-5- (N-n-propyl-N-formyl-amino-6-aminouracillus).
Příklad 4Example 4
Analogický postupu v příklade 1 s tým, že sa použije zmes 150 ml kyseliny mravčej a 50 ml. formannidu. Získá sa 60 g l-metyl-5-(N-n-propyl-N-formyl jamíno-6-amínouracilu.Analogous to the procedure of Example 1 except that a mixture of 150 ml formic acid and 50 ml is used. formannidu. 60 g of 1-methyl-5- (N-n-propyl-N-formyl jamino-6-aminouracil) are obtained.
Příklad 5Example 5
Analogický postupu v příklade 1 s tým, že sa použije zmes 150 mil kyseliny mravčej a 15 ml vody. Získá sa 48 g l-metyl-5-(N-n-propyl-N-formyljamíno-6-amínouracilu.Analogous to the procedure of Example 1 except that a mixture of 150 ml of formic acid and 15 ml of water is used. 48 g of 1-methyl-5- (N-n-propyl-N-formyl) amino-6-aminouracil are obtained.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS878787A CS261697B1 (en) | 1987-12-03 | 1987-12-03 | 1-methyl-5-/n-n-propyl-n-formyl/-amino-6-uracil and process for preparing thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS878787A CS261697B1 (en) | 1987-12-03 | 1987-12-03 | 1-methyl-5-/n-n-propyl-n-formyl/-amino-6-uracil and process for preparing thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CS878787A1 CS878787A1 (en) | 1988-07-15 |
CS261697B1 true CS261697B1 (en) | 1989-02-10 |
Family
ID=5438908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS878787A CS261697B1 (en) | 1987-12-03 | 1987-12-03 | 1-methyl-5-/n-n-propyl-n-formyl/-amino-6-uracil and process for preparing thereof |
Country Status (1)
Country | Link |
---|---|
CS (1) | CS261697B1 (en) |
-
1987
- 1987-12-03 CS CS878787A patent/CS261697B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CS878787A1 (en) | 1988-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4130564A (en) | Process for the manufacture of maleimides | |
CS261697B1 (en) | 1-methyl-5-/n-n-propyl-n-formyl/-amino-6-uracil and process for preparing thereof | |
US4140862A (en) | Salts of diamines and tetrahalophthalates | |
JPH01216976A (en) | Production of 1-hydroxyalkyl-5-nitroimidazole | |
US4585875A (en) | Process for preparing 4,4-bis-benz-ox(-thi,-imid)-azol-2-yl-stilbenes | |
US4925944A (en) | Process for the preparation of o-carboxypyridyl- and o-carboxyquinolylimidazolinones | |
US4182880A (en) | 1,8-Naphthyridine compounds and process for preparing the same | |
US4036841A (en) | Indolo[2,3α]quinolizine derivatives | |
US4160828A (en) | Analgesic phosphinyl compounds and compositions | |
DE69027300T2 (en) | 1,2-DIHYDRO-2-OXOQUINOXALINE DERIVATIVES, THEIR PRODUCTION AND USE IN THERAPY | |
US4841092A (en) | Preparation of tris(2-cyanoethyl)amine | |
JPH05501579A (en) | Method for producing quinophthalone derivatives | |
GB2092130A (en) | 4-Oximino-1,2,3,4- tetrahydroquinoline Derivatives | |
EP0393109B1 (en) | Novel 2,3-thiomorpholinedione-2-oxime derivatives, pharmaceutical compositions containing them and process for preparing same | |
US4017533A (en) | Diaminomaleonitrile derivatives and processes for preparing the same | |
US2899440A (en) | Process for the manufacture of | |
JPH062747B2 (en) | Process for producing 2-alkyl-4,5-dihydroxymethylimidazole | |
CA1110247A (en) | Process for preparing certain ethyleneglycol diesters | |
US4552967A (en) | Process for the synthesis of intermediates in the preparation of diaminopyridines | |
US4219650A (en) | Process for the preparation of pyrrolidonecarboxylic acid/metal/amine complexes | |
CA1162543A (en) | Process for the preparation of apovincaminic acid esters | |
EP0315902B1 (en) | Bis-indolyl ethylene aldehydes | |
SU508057A1 (en) | Tropic esters of 5-arylfuran-2-carboxylic acids, or their hydrochlorides, exhibiting local anesthetic activity, and method for their preparation | |
KR810001131B1 (en) | Process for preparing 3-piperidone derivatives | |
JPS6160673A (en) | Preparation of guanidinothiazole derivative |